HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Emmett T Cunningham Selected Research

pegaptanib

4/2009Pegaptanib sodium for macular edema secondary to central retinal vein occlusion.
11/2007Pegaptanib sodium for ocular vascular disease.
2/2006Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.
1/2006Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals.
10/2005A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.
12/2004Pegaptanib for neovascular age-related macular degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Emmett T Cunningham Research Topics

Disease

7Uveitis
12/2015 - 12/2003
7Retinitis
01/2015 - 12/2002
6Macular Degeneration (Age-Related Maculopathy)
06/2014 - 12/2004
6Macular Edema
01/2012 - 10/2005
5Retinal Detachment (Retinal Detachments)
01/2014 - 12/2002
5Inflammation
01/2014 - 12/2004
4Optic Nerve Diseases (Optic Neuropathy)
01/2015 - 12/2002
4Infection
12/2014 - 09/2006
4Anterior Uveitis
01/2014 - 03/2003
3Choroidal Neovascularization
12/2011 - 02/2006
2Wounds and Injuries (Trauma)
02/2015 - 05/2007
2Phlebitis
01/2015 - 01/2012
2Endophthalmitis (Ophthalmia)
12/2014 - 10/2005
2Neurosyphilis (General Paresis of the Insane)
02/2014 - 10/2012
2Central Serous Chorioretinopathy
01/2014 - 05/2006
2Panuveitis
01/2014 - 07/2010
2Necrosis
11/2013 - 11/2013
2Retinal Vein Occlusion
01/2012 - 11/2007
2Retinal Vasculitis
07/2010 - 12/2002
2Amyloidosis
02/2010 - 11/2007
2Scleritis (Episcleritis)
01/2009 - 12/2002
2Diabetic Retinopathy (Retinopathy, Diabetic)
11/2007 - 12/2003
2Vascular Diseases (Vascular Disease)
11/2007 - 02/2006
2Diabetes Mellitus
01/2006 - 12/2003
1Retinal Artery Occlusion
05/2015
1Atrophy
07/2014
1Epiretinal Membrane (Epiretinal Membranes)
06/2014
1Syphilis
02/2014
1Chorioretinitis
02/2014
1Microphthalmos
01/2014
1Heart Diseases (Heart Disease)
01/2014
1Retinal Hemorrhage
01/2014
1Melanoma (Melanoma, Malignant)
01/2014
1Bilateral Hearing Loss
01/2014
1Cataract (Cataracts)
01/2014
1Herpes Zoster
01/2014
1Congenital Rubella Syndrome (Syndrome, Congenital Rubella)
01/2014
1Edema
01/2014
1Keratitis
01/2014
1Acute Retinal Necrosis Syndrome
01/2014
1Pterygium
11/2013
1Granuloma
09/2013
1Metrorrhagia (Spotting)
10/2012
1Cicatrix (Scar)
01/2012
1Sympathetic Ophthalmia (Sympathetic Uveitis)
01/2012
1Telangiectasis (Telangiectasia)
03/2011
1Hemorrhage
07/2010
1Churg-Strauss Syndrome (Allergic Angiitis)
01/2009
1Fever (Fevers)
01/2008
1Arthralgia (Joint Pain)
01/2008
1Exanthema (Rash)
01/2008
1Infarction
01/2008
1Seizures (Seizure)
11/2007
1Retinal Neovascularization
01/2006

Drug/Important Bio-Agent (IBA)

16Retinaldehyde (Retinal)IBA
05/2015 - 12/2002
8Fluorescein (Funduscein)FDA LinkGeneric
01/2014 - 12/2004
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2011 - 12/2004
6pegaptanibFDA Link
04/2009 - 12/2004
5Adrenal Cortex Hormones (Corticosteroids)IBA
12/2015 - 12/2003
3SodiumIBA
04/2009 - 10/2005
2Multifocal choroiditisIBA
07/2014 - 01/2014
2secondary SyphilisIBA
09/2013 - 10/2012
2PapillitisIBA
12/2012 - 07/2010
2salicylhydroxamic acid (SHAM)IBA
12/2011 - 01/2006
2Prealbumin (Transthyretin)IBA
02/2010 - 11/2007
1Penicillins (Penicillin)FDA Link
01/2015
1Anti-Bacterial Agents (Antibiotics)IBA
12/2014
1Fluconazole (Zonal)FDA LinkGeneric
07/2014
1Carbon MonoxideIBA
06/2014
1Penicillin G (Benzylpenicillin)FDA LinkGeneric
02/2014
1FoscarnetFDA LinkGeneric
01/2014
1MethylprednisoloneFDA LinkGeneric
01/2014
1Ganciclovir (Cytovene)FDA LinkGeneric
01/2014
1Antiviral Agents (Antivirals)IBA
01/2014
1Acyclovir (Aciclovir)FDA LinkGeneric
01/2014
1SmokeIBA
01/2014
1Endothelial Growth FactorsIBA
11/2013
1Biological FactorsIBA
11/2013
1Triamcinolone (Aristocort)FDA Link
11/2013
1DiphosphonatesIBA
11/2013
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2013
1ranibizumab (Lucentis)FDA Link
12/2011
1Ritonavir (Norvir)FDA Link
03/2011
1bevacizumabFDA Link
01/2009
1Antinuclear AntibodiesIBA
01/2008
1Amyloid (Amyloid Fibrils)IBA
11/2007
1Congo RedIBA
11/2007
1AntigensIBA
05/2007
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
12/2004

Therapy/Procedure

3Vitrectomy
01/2012 - 11/2007
2Lasers (Laser)
02/2015 - 01/2012
2Aftercare (After-Treatment)
01/2015 - 02/2014
2Traction
06/2014 - 12/2005
2Trabeculectomy (Trabeculoplasty)
01/2014 - 11/2007
2Light Coagulation
01/2012 - 01/2006
2Highly Active Antiretroviral Therapy (HAART)
03/2011 - 09/2006
2Injections
01/2006 - 10/2005
1Penetrating Keratoplasty
01/2014
1Scleral Buckling
11/2013
1Organ Transplantation
05/2006